RADIRAD CO., LTD.

RadiRad Co., Ltd. specializes in medical devices focused on spinal applications. Their primary product, the RadiSpine system, appears to leverage AI-driven imaging or diagnostic tools to assist in spinal assessments and interventions. The company’s offerings are centered on enhancing precision and efficiency in radiology-related procedures.

RadiRad Co., Ltd. is headquartered in Taiwan. While the company’s location determines its primary regulatory jurisdiction (e.g., adherence to Taiwan’s medical device regulations), its devices may also be listed in international registries like the EU’s eudamed database. This dual presence allows healthcare providers and regulators in different regions to access information about the device’s classification and registration status.

RadiRad Co., Ltd.’s devices, such as the RadiSpine system, are listed in the EU’s eudamed database. This registry is critical because it provides transparent, publicly accessible information about medical devices authorized for use within the European Economic Area. Listing in eudamed helps healthcare professionals, hospitals, and regulatory bodies verify the device’s classification (e.g., Class I) and compliance with EU requirements.

RadiRad Co., Ltd.’s devices, including the RadiSpine system, are classified as Class I medical devices. This classification is the lowest risk tier under EU regulations, typically reserved for devices that pose minimal risk to patients, such as certain diagnostic tools or simple surgical instruments. The classification reflects that the device undergoes fewer regulatory scrutiny and conformity assessment procedures compared to higher-risk classes.

Based on the available information, RadiRad Co., Ltd. currently focuses on spinal applications through its RadiSpine system. While the company’s marketing highlights AI solutions for both heart and spine, only the RadiSpine device is explicitly mentioned in the provided data. Without additional details, it’s unclear whether other device lines exist or are in development.